Purpose: Preimplantation genetic diagnosis (PGD) is an important option for couples at risk of having children with
INTRODUCTION
Preimplantation genetic diagnosis (PGD) is an option for couples at risk for producing offspring with thalassemia, to avoid termination of an affected fetus following prenatal diagnosis. Some of these couples have the unfortunate experience of undergoing two or more terminations of wanted pregnancies before they have a healthy child. PGD has already been applied to more than 700 couples at risk of having children with single gene and chromosomal disorders resulting in the birth of more than a hundred unaffected children (1) . Although PGD for thalassemia and sickle cell disease was performed for only a few cases, it could be used more extensively if it were available in the Mediterranean region and other areas of the world where thalasemias are most prevalent. For example, in Cyprus, where almost no new thalassemia cases have been observed in the past few years, more than a quarter of couples experience two or more pregnancy terminations following prenatal diagnosis (2) . This paper presents the first clinical experience of PGD of thalassemias, demonstrating the accuracy and reliability of the polar body (PB) PGD of B-globin gene mutations.
MATERIALS AND METHODS
PGD of p-thalassemias was performed in 12 clinical cycles (8 cycles for IVS1-110 and 4 for IVSII-745), using biopsy of the first (I) and second (II) PBs. Oocytes were obtained after a standard in vitro fertilization (IVF) stimulation procedure, and their IPBs were removed and used for polymerase chain reaction (PCR) analysis as described elsewhere (3) . Second PBs were removed following fertilization in the same way as IPBs. To avoid possible contamination by sperm DNA in the follow-up PCR analysis of IIPBs, assisted fertilization by intracytoplasmic sperm injection (ICSI) was applied.
DNA analysis of IPBs and IIPBs was performed using nested PCR to amplify the affected sequence from IPB and IIPB followed by restriction digestion (4) . Depending on the thalassemia mutation studied, different primer systems were designed (Table I, Figs.  1 and 2) . Because of the possibility of preferential amplification or allele dropout (ADO) in single-cell PCR analysis (4, 8, 9) , simultaneous detection of two highly polymorphic markers, short tandem repeats (STRs) 5' to the B-globin gene and HUMTH01 (10, 11) , were performed. The 5' locus is tightly linked to B-globin gene. To identify possible contamination of the IPB and IIPB DNA samples by maternal follicular cells or sperm DNA, two systems for STR loci on chromosome 21 and VWF gene on chromosome 12 were also tested (12, 13) . The conditions of PCR analysis are presented in Table II .
Following nested amplification, PCR products were digested with either Mbo1 for IVSI110 or Rsa1 for IVSII 745 and analysis was carried out on 6% polyacrylamide gels. Gels were photographed as described Ref.
(5) previously (4) . Statistical analyses were performed using chi-square analysis in the computer program Epistat. The embryos resulting from the oocytes whose IPB and IIPB analysis predicted the presence of unaffected maternal allele were transferred back to woman to achieve a pregnancy, while affected embryos were used for confirmation of the IPB and IIPB diagnosis.
RESULTS AND DISCUSSION
Before clinical application, the efficiency of amplification by the above multiplex system and ADO rates were studied using single fibroblasts, isolated from patients' skin cultures. The results of amplification efficiency and ADO rates in single fibroblasts obtained from individuals heterozygous for different B-globin Table IV . The majority of the oocytes studied by IPB were heterozygous for the mutant genes (87 of 118), as well as for polymorphic markers (65 of 86). The genotype of the gametes resulting from these heterozygotes may be evaluated only by testing of their IIPBs. Of 89 oocytes studied by IIPB, 78 were tested by both IPB and IIPB. The resulting genotypes from these oocytes are presented in Table V and demonstrate that analysis of the IIPB increases considerably the number of oocytes with established diagnosis as compared to IPB analysis alone. The number of unaffected oocytes after IIPB testing increased from 6 to 31, by adding 25 additional unaffected hemizygote oocytes which had heterozygote IPB. Consistent results were obtained for polymorphic markers. This demonstrates that analysis of oocytes by sequential IPB and IIPB removal allows accurate genotyping for the majority of aspirated oocytes (76 from 78 oocytes for the B-globin gene and 60 of 62 for polymorphic markers). In a " These numbers do not correspond to the numbers of oocytes, because STRs and mutations were studied simultaneously in the same oocytes. a These numbers do not correspond to the numbers of oocytes, because STRs and mutations were studied simultaneously in the same oocytes. Fig. 3 . Preimplantation genetic analysis of polar bodies and blastomeres for the 1VS1-110 thalassemia mutation (Mbo1 restriction digestion). Left: Case 1. Right: Case 2. #, oocyte sequential number; 1 Pb, first polar body; 2 Pb, second polar body; BL, blastomere; ET*, embryo transfer; T, thalassemia allele; N, normal allele. 79, 79-bp undigested thalassemia allele; 58 = 58-bp restriction fragment (normal allele). In case 1, embryos 3 and 10, resulting from oocytes with a heterozygous polar body and a hemizygous abnormal second polar body, have been transferred. In case 2, embryo 1, resulting from oocyte with a heterozygous first polar body (signal for mutant allele was very weak and not seen here) and a hemizygous abnormal second polar body, have been transferred. Embryo 3 in this case was also transferred based on the results of the first polar body, containing abnormal allele, and the results of blastomere biopsy, showing the presence of only normal allele (the data from correspondingly second polar body were not available). small number of oocytes the genotype of the resulting gamete could not be predicted (in two oocytes each for thalassemia and the polymorphic markers) because of ADO, which could have led to misdiagnosis without use of the sequential analysis of both PBs.
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The results of the follow-up study in the embryos resulting from the oocytes predicted to be affected by both IPB and IIPB (Table IV) show that the predicted genotypes of the embryos were confirmed in 50 of 51 cases for mutant alleles, as well as in all cases for polymorphic markers. The study of 37 embryos heterozygous for IVSI-110 B-globin mutation and predicted to be affected demonstrated a statistically significantly higher ADO rate in blastomeres (18.6%) than in fibroblasts (10.1%; P = 0.001) (Tables III and VI) . Of 161 blastomeres obtained from these 37 embryos, both alleles amplified in 132 (81.4%) of 161 blastomeres analyzed for thalassemia mutations and in 41 (81.9%) of 51 blastomeres studied for polymorphic markers, demonstrating a greater risk of misdiagnosis in PGD based on blastomeres. We have also noted a higher ADO rate in blastomeres than in IPBs, but this difference did not reach statistical significance. Applying a simultaneous amplification of linked polymorphic markers is of great value to decrease the undetected ADO rate and the risk for misdiagnosis, especially when the parents are carriers of different B-globin gene mutations. Of 78 oocytes studied by both IPB and IIPB, 30 embryos predicted to carry the unaffected maternal allele were identified and transferred in 11 cycles, resulting in two ongoing pregnancies, both of which have already been confirmed to be free of the maternal B-globin mutation (Table VII) .
The results of PGD in cases of IVSI-110 are demonstrated in Fig. 3 , showing the details of the PCR analysis in the identification of IVSI-110 free embryos for transfer. Embryos 3 and 10 in case 1, and 1 in case 2 resulted from oocytes whose IPBs were heterozygous and IIPBs hemizygous affected. The follow-up genotyping of 51 embryos resulting from oocytes tested by both IPB and IIPB analysis confirmed the predicted PB diagnoses in all but one of them (Table IV) , demonstrating the accuracy of the IPB and IIPB analysis for PGD of B-thalassemias.
This demonstrates the accuracy and feasibility of the technique of the sequential PB analysis for the preimplantation diagnosis of Mendelian disorders, with increased accuracy of diagnosis resulting from the use of linked markers. Because of the increased ADO rate observed in blastomeres with respect to PBs, we cannot endorse blastomere analysis alone for PGD of Mendelian disorders when both parents have different mutations or in dominant disorders.
